Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis.
Szekanecz Z, Haines GK, Lin TR, Harlow LA, Goerdt S, Rayan G, Koch AE. Szekanecz Z, et al. Among authors: Harlow LA. Arthritis Rheum. 1994 Feb;37(2):221-31. doi: 10.1002/art.1780370211. Arthritis Rheum. 1994. PMID: 8129777
Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease.
Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, Lin SJ, Rayan G, Koch AE. Szekanecz Z, et al. Among authors: Harlow LA. Clin Immunol Immunopathol. 1995 Aug;76(2):187-94. doi: 10.1006/clin.1995.1114. Clin Immunol Immunopathol. 1995. PMID: 7614737
Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.
Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE. Volin MV, et al. Among authors: Harlow LA. Am J Pathol. 2001 Oct;159(4):1521-30. doi: 10.1016/S0002-9440(10)62537-0. Am J Pathol. 2001. PMID: 11583978 Free PMC article.
Evidence of IL-18 as a novel angiogenic mediator.
Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. Park CC, et al. Among authors: Harlow LA. J Immunol. 2001 Aug 1;167(3):1644-53. doi: 10.4049/jimmunol.167.3.1644. J Immunol. 2001. PMID: 11466388 Free article.
Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.
Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA, Woodruff DC, Burdick MD, Strieter RM. Koch AE, et al. Among authors: Harlow LA. Arthritis Rheum. 2001 Jan;44(1):31-40. doi: 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4. Arthritis Rheum. 2001. PMID: 11212173 Free article.
Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, Koch AE. Volin MV, et al. Among authors: Harlow LA. Arthritis Rheum. 1999 Sep;42(9):1927-35. doi: 10.1002/1529-0131(199909)42:9<1927::AID-ANR19>3.0.CO;2-X. Arthritis Rheum. 1999. PMID: 10513809 Free article.
Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.
Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM. Koch AE, et al. Among authors: Harlow LA. J Clin Invest. 1994 Mar;93(3):921-8. doi: 10.1172/JCI117097. J Clin Invest. 1994. PMID: 8132778 Free PMC article.
Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1992. J. Clin. Invest. 90:772; Koch, A. ...Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Science (Wash. DC). 258:1798). Recently, m phi inflammatory protein-1 (MIP-1 alpha), a cytokine with chemotactic activity for m phi s and neutrophils (PMNs), has been described. ...
Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1992. J. Clin. Invest. 90:772; Koch,
23 results
Jump to page
Feedback